Clinical information
Diagnostic Utility:
This is the quantitative detection of antibodies against the surface antigen of the hepatitis B virus (anti-HBs), and its determination is useful in:
- Determining the degree of immunity to the hepatitis B virus in individuals who have been exposed to HBV and/or in vaccinated individuals.
- Transfusion of blood products, progenitor cells, umbilical cord blood cells, solid organs, and tissues.
Method:
Chemiluminescent Microparticle Immunoassay (CMIA).
Reference Values
The possible result is: Quantitative Value (mIU/mL).
Diagnostic Algorithm:
Not applicable
Response Time:
Maximum 2 working days.
Specimen information
Sample: Serum and/or plasma.
Tube: 1-5 mL aliquots, plasma tubes with EDTA, sodium citrate, ACD, CPDA-1, or sodium heparin as anticoagulant and/or serum tube with or without separator.
Minimum essential volume: 1 ml
Stability:
- At room temperature: ≤ 3 days
- In refrigeration: ≤ 14 days
- Sample frozen at or below -20ºC: 10 years
Transport instructions: Preferably at room temperature if it is whole blood tubes and refrigerated if it is serum and/or plasma aliquots.
Reasons for rejection: Highly hemolyzed sample.
Administrative information
BST Code: 0100
Test Description: Hepatitis B, Anti-surface antigen antibodies
Synonyms: anti-HBs
Section: Transfusion Safety Laboratory
BST Rate: Check the updated rates here.
Profiles:
Not applicable.
References
- Inserts kits de Anti-HBs Architect, Abbott.
Quality
BST holds ISO 9001, ISO 14001, and OSHAS 18001 quality certifications, as well as the European Excellence 500+ seal. BST is accredited by CAT, JACIE-FACT, FACT-NETCORD, and EFI, and complies with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines.